Home > Healthcare & Medical Devices > Endometrial Ablation Devices Market
Endometrial Ablation Devices Market Size is projected to amass considerable gains over 2022-2028, on account of the myriad benefits of uterine ablation procedures, such as reduced risks of uterine infection and faster recovery. In addition, the rapid advancements in minimally invasive surgical techniques and the high burden of gynecological disorders like cervical cancer will also proliferate the adoption of endometrial ablation procedures in the upcoming years. Endometrial ablation refers to a minimally invasive surgical procedure designed to treat heavy menstrual bleeding. In this procedure, the lining of the uterus (endometrium) is removed to treat conditions including heavy periods, endometriosis, and fibroids.
Rising burden of hormone disorders like polycystic ovary syndrome (PCOS) among women is one of the major factors amplifying the endometrial ablation devices market over 2022-2028. As per the Endocrine Society’s data, PCOS affects around 5%-20% of all women of reproductive age and is the leading cause of infertility, which is likely to contribute to the overall industry forecast. Moreover, the high emphasis on boosting awareness of gynecological cancer, along with the growing incidence of adenomyosis in women, particularly after 50 years of age, will also assert a positive influence on endometrial ablation surgery demand globally. Despite these favorable growth environments, the risks and complications associated with uterine ablation surgery such as uterine perforation, shortness of breath, and high fever may create a hindrance to the market dynamics to a certain extent.
Cryoablation technology segment is anticipated to hold a considerable share in the endometrial ablation devices market by 2028. Growth from the segment can be credited to the high safety and less-invasive nature of the cryoablation procedure as compared to surgery. Fewer side effects, cost-effectiveness, and less damage to surrounding tissues, among other advantages of this technology will further push segmental expansion over the coming years.
Europe endometrial ablation devices market will register appreciable revenue by 2028, considering the robust healthcare system in countries like Germany, especially with regards to hospital beds, trained staff, and infrastructure. Furthermore, according to the National Health Service’s statistics, nearly 260 women are diagnosed with vaginal cancer each year in the UK. Such factors, alongside the escalating healthcare expenditure and the high prevalence of cervical cancer in countries like the UK and France, are expected to fuel the regional market outlook in the years ahead.
The competitive landscape of the endometrial ablation devices industry consists of companies such as AngioDynamics, Medtronic, Richard Wolf GmbH, Karl Storz GmbH & Co. KG, Hologic, Inc., The Cooper Companies Inc., Smith & Nephew, Minerva Surgical, Olympus Corporation, and Boston Scientific Corporation, among others. These firms are focusing on new product launches and acquisitions, among other strategies to reinforce their footprint in the competitive market.
For instance, in November 2021, Hologic, Inc. announced plans to launch its global endometrial ablation device, NovaSure V5, at the AAGL (American Association of Gynecologic Laparoscopists) 50th Global Congress to help achieve better outcomes for women. In February 2021, Cooper Companies’ subsidiary CooperSurgical acquired AEGEA Medical and its Mara endometrial ablation treatment, to expand its product portfolio focused on women’s health.
Lifestyle changes and increased stress amid the novel coronavirus pandemic have affected menstrual cycles worldwide, which could increase demand for endometrial ablation devices. Following COVID-19 vaccination, multiple women across the globe observed irregularities in their menstrual bleeding, with menorrhagia and heavy or frequent bleeding before the periods being common symptoms witnessed among women after their shots. These potential irregularities in the menstrual cycle are likely to generate opportunities for the endometrial ablation devices industry growth over the forthcoming years.
Market, by Technology
Market, by End-use
The above information is provided for the following regions and countries: